search
IBRX
Trends
- 1SLS and IBRX climb as Moderna joins Nasdaq-100▼SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot
SLS and IBRX shares rose in overnight trading while retail investors turned their attention to Moderna after the biotech was added to the Nasdaq-100 index. Traders are watching whether Moderna's inclusion sparks a broader rally in biotech names, with retail chatter focused on momentum across MRNA and related small-cap stocks heading into the next session.
- 2Retail biotech favorites SLS, IBRX, VNDA, IOVA vs September slump▼Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump?
Biotech stocks lagged the broader market in September, with the SPDR S&P Biotech ETF (XBI) falling while the wider market held up better. Attention is now on whether retail-favored names SELLAS Life Sciences (SLS), ImmunityBio (IBRX), Vanda Pharmaceuticals (VNDA) and Iovance Biotherapeutics (IOVA) managed to escape the sector's slump. Investors are weighing whether these popular small-cap biotechs diverged from the wider sector weakness.
- 3Stock Futures Rise Ahead of Jobs Report Despite Higher Yields▼Dow, S&P 500, Nasdaq Futures Rise Despite Soaring Treasury Yields As Markets Eye Jobs Report: MU, NKE, IBRX, CEG Stocks In Focus
US stock index futures pointed higher despite a sharp rise in Treasury yields, with investors focused on the upcoming jobs report for signals on the economy and interest rate outlook. Micron, Nike, iBio-branded Ibrx and Constellation Energy shares were flagged as stocks to watch in the session ahead.